| AE(s) | Adverse Event(s) |
| ALT | Alanine Aminotransferase |
| AST | Aspartate Aminotransferase |
| EMA | European Medicines Agency |
| EGCG | Epigallocatechin Gallate |
| FDA | Food and Drug Administration |
| GTE | Green Tea Extract |
| ICSR(s) | Individual Case Safety Report(s) |
| JBI | Joanna Briggs Institute |
| MAH(s) | Marketing Authorization Holder(s) |
| MRI | Magnetic Resonance Imaging |
| PRISMA-ScR | Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews |
| PT(s) | Preferred Term(s) |
| RCT(s) | Randomized Controlled Trial(s) |
| RUCAM | Roussel Uclaf Causality Assessment Method |
| SAE(s) | Serious Adverse Event(s) |
| SOC(s) | System Organ Class(es) |
| TCM | Traditional Chinese Medicine |
| UMC | Uppsala Monitoring Centre |
| WHO | World Health Organization |